Skip Nav Destination
Issues
"New" psychotropics: New chemical entities and new dosage forms, Vol. 4, Iss. 1
-
Cover Image
Cover Image
![issue cover]()
2022 MHC Awards and Recognition
Erica A. K. Davis, PharmD, BCPS, BCPP, Amy VandenBerg, PharmD, BCPP
A preliminary evaluation of N-acetylcysteine's effects on patient adherence to treatment for cocaine use disorder
Jake Schechter, DNP, PMHNP-BC, RN, Geoffrey W. Brown, PharmD, Maria Janda, PharmD
Post hoc depression analysis from a pharmacist-led diabetes trial
M. Thomas Bateman, PharmD, BCACP, Caitlin McCarthy, PharmD, BCPP, Katherine M. Prioli, MS, Mary L. Wagner, MS, PharmD
Best practices for documentation of psychotropic drug-drug interactions in an adult psychiatric clinic
Kathryn Collins, PharmD, MSPH, Julie A. Dopheide, PharmD, BCPP, FASHP, Mengxi Wang, MPH, Talene Keshishian, MD
Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
Kaitlyn Morgan, PharmD, BCPP, Leah Rickert, PharmD, BCPP
